Tscan Therapeutics Inc. (TCRX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 7,857,347 $14,300,372 2.91%
2. 5,226,074 $9,511,455 0.39%
3.
Baker Bros. Advisors

Julian Baker And Felix Baker

2,784,792 $5,068,321 0.04%
4.
Propel Bio Management

Leen Kawas And Richard Kayne

1,932,304 $3,516,793 -8% 3.52%
5. 829,919 $1,510,453 +5% 0%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$0.90 6,232 $5,601.94 8,019,148 2025-12-23 Filing
$0.90 75,500 $67,950.00 8,012,916 2025-12-22 Filing
$0.90 80,069 $71,974.02 7,937,416 2025-12-19 Filing
$1.20 1,200,000 $1,440,000.00 7,946,141 2025-05-20 Filing
$1.20 1,388,794 $1,666,552.80 6,746,141 2025-05-19 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$5.78 164,686 $952,115.64 4,716 2024-08-23 Filing
$2.51 400 $1,003.00 5,224,600 2023-05-31 Filing
$2.52 15,000 $37,801.50 5,225,000 2023-05-31 Filing
$2.51 10,000 $25,148.00 5,240,000 2023-05-31 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 2,382,764 $4,336,629 0%
2. 2,317,916 $4,218,607 0%
3. 1,354,820 $2,465,772 0%
4. 1,245,504 $2,266,817 0.2%
5. 1,077,080 $1,960,286 0.08%
News See All